With emphasis on multidisciplinarity and innovation, this meeting will specifically cover the main following topics: - Biological patient profiling and risk factors - Emerging diagnostic and therapeutic tools - Functional outcome of treatments - Management of elderly patients - Recurrent and metastatic disease - Clinical controversies based on case discussions, such as sequential vs concomitant chemotherapy vs concomitant targeted agents, post-chemo-radiotherapy neck dissection, etc.